Receive The Newest Study Notifications

IMAGE: TERESA MEIER, M.D., ASSISTANT PROFESSOR OF RADIATION ONCOLOGY AT THE UC COLLEGE OF MEDICINE AND A UC HEALTH RADIATION ONCOLOGIST, IS STUDYING THE EFFECTS OF PROTON RADIATION THERAPY ON PATIENTS... view more  CREDIT: COLLEEN KELLEY CINCINNATI--Researchers at the...

Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has entered into a collaboration with the Alliance for Clinical Trials in Oncology Foundation (Alliance), a US-based cancer...

Mary Terry for Biospace writes: T3D Therapeutics, based in Research Triangle Park, NC, received a $9 million grant over four years from the National Institute on Aging (NIA), part of theNational Institutes of Health (NIH). The funds will be used to partially support a...

Strata Oncology, Inc., a precision oncology company, today announced that data from its Strata Trial, a nationwide observational NGS screening protocol providing no-cost tumor sequencing and clinical trial matching for 100,000 advanced cancer patients, will be...

Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced that the Company has completed its Type C CMC meeting and has reached agreement with the U.S. Food and...

RVT-1601 previously demonstrated a statistically significant and clinically meaningful reduction in IPF-related cough in a Phase 2a study Respivant also launches new website - IPFCough.com - as educational resource for patients and to increase awareness of the...

Masimo  (NASDAQ: MASI) announced today the results of a study published in BMC Anesthesiology in which clinicians at Peking Union Medical College in Beijing evaluated the ability of noninvasive and continuous hemoglobin monitoring with Masimo SpHb ® to help clincians...

SpringWorks Therapeutics Announces Initiation of Phase 3 Trial (DeFi) of Nirogacestat in Adult Patients with Desmoid Tumors More STAMFORD, Conn.--(BUSINESS WIRE)-- SpringWorks Therapeutics, a clinical-stage biopharmaceutical company focused on developing life-changing...

Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and leader in predictive target discovery, today announced that it has dosed the first patient in the combination arm of its Phase 1 study, combining escalating doses of COM701 with a fixed...

 Spatz Medical today announced the FDA trial results of its innovative adjustable gastric balloon. The results demonstrate that the Spatz3 balloon is significantly more effective than any non-adjustable balloon in the market. For the past 30 years, gastric balloons...

The Breakthrough Discovery Using Breast Milk Will Complete in 2019 A research group in Lund, led by Professor Catharina Svanborg, discovered in 1995 that a component of human breast milk kills tumour cells without harming mature, healthy cells. Further experiments and...

Numbers have reached record highs with over 870,000 clinical trial participants involved in research studies supported by the National Institute for Health Research (NIHR) over the last year This high number takes significant steps towards the NHS Long Term Plans...

Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has entered into a collaboration with the Alliance for Clinical Trials in Oncology Foundation (Alliance), a US-based cancer...

Pep Therapy, a biotechnology company developing peptides as targeted therapies for oncology, announces that its first-in-class drug candidate, PEP-010, successfully completed Good Laboratory Practice (GLP) toxicity study, moving towards its first-in-human clinical...

Studies represent work of more than 60 Dana-Farber Cancer Institute led research teams Three researchers are recipients of ASCO’s Special Awards, the Society’s highest honors Boston – Dana-Farber Cancer Institute researchers are presenting more than 70 research...

Tools4Patient, S.A., developer of tools to optimize and accelerate drug development programs, today announced it raised €4 million ($4.5 million) in an oversubscribed Series B equity financing round. New institutional investors include Innovation Fund and Sambrinvest....

In a National Institutes of Health-funded randomized controlled clinical trial, To Quit, MindSciences' smoking cessation app, has shown a dose-dependent relationship between app use and reduction in cigarette smoking.  The trial involved 67 subjects who received...

Presented at the World Advanced Therapies & Regenerative Medicine Congress & Expo 2019 Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company“), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases,...

National Cancer Institute (NCI) Study Designed to Investigate Zotiraciclib in Combination with Temozolomide (TMZ) for the Treatment of Recurrent Malignant Gliomas Adastra Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of proprietary...

Before being diagnosed with malignant mesothelioma, Raya Bodnarchuk was already being celebrated as a noted artist and sculptor who taught at the Corcoran School of Art in Washington, D.C.  But most recently she was recognized for an entirely different reason: she and...